Congress · 01. February 2018
SYnAbs attended Innovation for Health congress in Rotterdam, Netherlands to promote custom mAb generation services in rat and guinea pig species to obtain monoclonal antibodies of higher affinity and better specificity against difficult targets
Congress · 20. November 2017
SynAbs attended Medica congress in Germany to meet In-Vitro Diagnostic players for monoclonal antibodies discussions

Congress · 21. June 2017
SynAbs has been welcome to Pivotal Scientific community and has presented its recent achievements in custom monoclonal antibody generation against oncology biomarkers
Congress · 24. May 2017
SynAbs attended BioMed congress in Israël to investigate Tel-Aviv booming biotechnology sector and needs in custom monoclonal antibodies of higher affinity and specificity

Congress · 18. May 2017
SynAbs attended K4G event to expose its portfolio of rat secondary monoclonal antibodies targeting mouse, rat, human and anti-species repertoires
Congress · 10. May 2017
SynAbs has been welcomed by WBC to expose its unique development strategy in rat and guinea pig monoclonal antibodies for biotech and IVD players